Threat Of Cronobacter Contamination For Powder Infant Formula Rings Clear In Latest US Recall

Finding ‘One Of Most Troubling’ Pathogen Groups For Dry Foods Is ‘Needle In Haystack’

Reckitt's identification of Cronobacter sakazakii as contaminant in its 145,000-can Enfamil recall is latest clear statement about Cronobacter bacteria potentially disrupting supply of formula and other nutritionals distributed in powder form.

Cronobacter sakazakii isn't as easy to find in the field as examining a colony of the bacteria on an agar plate. • Source: Shutterstock

An Enfamil product is the latest powder infant formula on recall due to potential Cronobacter species bacteria contamination in nutritional products distributed in the US since an unsafe level was found in an Abbott plant and led to an ongoing shortage of formula products.

Reckitt Benckiser Group PLC’s announcement about its Mead Johnson Nutrition Co. business’s recall published on 20 February by the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Supply Chain

Wellness Firms Targeting GLP-1 Patients’ Dietary Needs Keep Option To Provide Access To Oral Rx

Health and wellness brands and retail chains providing access to prescriptions for compounded GLP-1 drugs, most also offering supplements curated to help meet dietary needs of GLP-1 patients, are offering formulations in oral form as well as injection.

Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s Jasper Crone

 
• By 

HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.

US Consumer Health, Beauty Sectors: Expecting Tariff Policy Changes, Buckling Up For The Ride

 

As firms in OTC drug, dietary supplement and personal care/beauty sectors reported results for January-March period after Trump announced reciprocal tariffs, they buckled up for more changes in the president’s thinking likely to affect consumer spending as well as their costs.

OTC Drug, Supplement Trade Groups Argue For Tariff Exemption, International Supply Chain

 

Potential for supply disruption coupled with manufacturers’ costs for moving supply chains to US emphasized by industry trade groups in comments submitted to Department of Commerce on whether pharmaceutical and dietary ingredients should remain exempted from tariffs President Trump has imposed.

More from HBW Insight

US FDA Extracts More Evidence To Ban Kratom

 

Recent warning letters to seven companies marketing products with kratom extract known as 7-OH are FDA’s first in three years referencing unlawful products containing kratom and the first of all its kratom-related warnings to reference extracts from the botanical.

House OMUFA Reauthorization Bill Takes On Clarifying Standards For Tests To Meet GRASE

 

Health Subcommittee will discuss reauthorizing OMUFA during a hearing on how to “maintain and improve” the public health workforce and rural health as well as access to OTC medicines.

Beauty Market Uncertainty Stalls Large M&A, But Middle-Market Deals Continue – Capstone

 

Middle-market beauty deals, which are defined as those with targets of $10m to $100m worth of enterprise value, are driving transaction momentum year-to-date that is in-line with levels during the same period last year, according to Capstone Partners’ Consumer Investment Banking Group.